Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Cognition Therapeutics shares surged after the clinical-stage company said it completed the end-of-Phase 2 meeting with the Food and Drug Administration for its zervimesine drug. Shares were up 30% at ...

The federal judge reignited the legal standoff over President Trump’s efforts to deny citizenship to children born to ...

A voluntary recall has been issued for select Ritz Peanut Butter Cracker Sandwiches that may be incorrectly labeled and cause ...

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

From offering financial advice to chair massages, Montgomery County residents are finding ways to support local laid-off ...

The FDA announced a voluntary recall of four sizes of Ritz Peanut Butter Cracker Sandwiches due to a serious labeling issue.

The deal hands AbbVie a drug that’s shown early promise in multiple myeloma and may be useful treating other cancers and ...

Although 40 states have legalized medical marijuana, the federal government still lists it as a controlled substance.

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

A growing disconnect remains between what generics are approved and what are actually accessible, GoodRx said.